Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Direvo Validates BluZy™ Technology in Collaboration with US CCUR

Published: Friday, December 21, 2012
Last Updated: Friday, December 21, 2012
Bookmark and Share
Company has successfully completed the scale up of BluZy™-D and BluZy™-P.

Direvo Industrial Biotechnology GmbH has successfully completed the scale up of its first two products BluZy™-D and BluZy™-P in collaboration with the Center for Crops Utilization Research (CCUR) and the BioCentury Research Farm (BCRF) at Iowa State University.

A team led by Dr. Larry Johnson, director of CCUR and BCRF, conducted lab-scale and pilot-scale trials to test the effects of the enzyme technology on ethanol production and processed samples of enzyme-modified DDGS and unmodified DDGS for analytical and nutritional comparison purposes.

From this work, Direvo validated the performance of BluZy™-D that substantially improved nutritional value as compared to commercially available DDGS.

The production was further scaled up at BCRF where more than one ton of DDGS was produced for further evaluation in broiler feeding trials at major universities in the US.

BluZy™-P the second product of Direvo´s BluZy™ product development platform was also evaluated by the experts at BCRF. BluZy™-P improved process efficiency of ethanol production at multiple steps and significantly simplified back end oil separation.

“The pilot-scale facilities for dry-grind ethanol production at BCRF offered Direvo the ideal opportunity to test this new and unique technology prior to full-scale production,” said Klaudija Milos, Vice President Business Unit Industrial Solutions.

Milos continued, “Our recent project results demonstrate the validity of our technologies and the economic benefit for two large industries in the US, ethanol and animal production.”

Direvo will be exploring various industry opportunities as it proceeds in scaling up the BluZy™-Technology for commercial operations.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

European and US Cellulase Patents Granted to Direvo
Granted patents describe improved cellulase enzymes having CBH II activity.
Wednesday, May 22, 2013
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Biological Link between the Gut Microbiome and Parkinson’s Disease
The findings suggest that targeting the gut microbiome may provide a new approach for diagnosing and treating Parkinson’s disease.
How the Brain Recognizes Faces
Machine-learning system spontaneously reproduces aspects of human neurology.
Boosting Effectiveness of Asthma Therapy
A team of scientists from UCSF has developed a new treatment to dampen bronchospasm.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!